Interferon-α adjuvant therapy decreases the recurrence of early clear cell renal cell carcinoma and improves the prognosis of Chinese patients

The survival time of patients with early clear cell renal cell carcinoma (ccRCC) is fairly long, but 20% to 30% of patients with localized tumors experience relapse, and the effect of IFN-α on survival has not been well studied in patients with early ccRCC. In this study, 208 patients with early ccR...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Hang, Liao, Cheng-Gong, Huang, Jian-Guo, Wang, Yong-Qiang, Li, Zheng, Fan, Lu-Lu, Qian, Men-Long, Wan, Nao, Lu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762582/
https://www.ncbi.nlm.nih.gov/pubmed/29348897
http://dx.doi.org/10.18632/oncotarget.18567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762582/
https://www.ncbi.nlm.nih.gov/pubmed/29348897
http://dx.doi.org/10.18632/oncotarget.18567

Ejemplares similares